Dudediligence.

Humacyte, Inc

HUMANASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$82,294

2 notices · 91,774 sh

Oct 2025 to Oct 2026

Reported ·

$82,597

2 sales · 2 buys · $59,790 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

All 2 reported sales carry the 10b5-1 box. Together they are 0.03% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-05-18: Sander Dale A., Form 1442026-05-18: Parikh Shamik J, Form 1442026-05-18: Constantino Michael T., bought2026-05-18: Sander Dale A., sold2026-05-18: Parikh Shamik J, sold2026-05-19: Sebelius Kathleen, bought
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-05-18Sander Dale A., CFO and Chief Corp. Dev. Off$41,147
45,887 shplan 2025-12-05144 ↗
Form 4, 2026-05-20: sold 45,887 at $0.90 Form 4 ↗
2026-05-18Parikh Shamik J, Chief Medical Officer$41,147
45,887 shplan 2025-12-06144 ↗
Form 4, 2026-05-20: sold 45,887 at $0.90 Form 4 ↗